In an increasingly litigious era of medicine, it becomes easy to over-test, over-treat, and generally over-do some basic urgent issues in the outpatient setting. This course will review some of the most common urgent outpatient complaints and evidence-based diagnostics and therapeutics that can let both you and your patient rest well without breaking the bank. We will focus on pearls for high-value care and reinforce the importance of thorough history-taking and physical exams, as they are the most valuable and least expensive tools in the clinician’s toolkit. After this review of evidence-based criteria that will allow you to proceed confidently when further management is indicated, you can reassure your patients that more isn’t always better.
Primary care providers frequently encounter various types of chronic non-cancer pain in their practice, including chronic low back pain, chronic headache, fibromyalgia, neuropathic pain, osteoarthritis, and others. Best practices for the management of chronic non-cancer pain consist of a multimodal approach, with the optimal incorporation of non-opioid treatment approaches. This session will describe multiple approaches to non-opioid pain management for the primary care. Strategies include both pharmacologic and non-pharmacologic approaches as well as interventional approaches. Recognizing that some of these may require referral to a specialist, the primary care provider, with heightened awareness of multiple non-opioid pain management treatments, will be able to more comprehensively evaluate and treat their patients with chronic pain.
This talk will review the pathophysiologic mechanisms of pain and how to best address them.
This activity will outline current guidelines for management of various types of pain as well discuss risk management strategies when prescribing opioids.
This presentation will review the history and current policies related to cannabis use in California, with an emphasis on how recent legalization and ongoing medical marijuana clinics impact primary care. The faculty will review how cannabis is consumed and discuss the scientific basis of what is known about therapeutic and harmful effects. You will walk away from this session with a roadmap on how to address cannabis use in inpatient and outpatient treatment settings and how to answers questions from patients and families
This activity will discuss the epidemiology and pathophysiology of acute and chronic pain, patient assessment, assessment of risk for opioid-related aberrant behaviors, nonpharmacologic approaches to pain management, and non-opioid analgesics. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 3/19/2020 and they are subject to change as new information is published.
This activity will review the general principles of opioid prescribing, key concepts including misuse, abuse, tolerance, physical dependence, opioid use disorder, adverse effects and metabolism of opioids, and instructions for safe storage and disposal. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 3/19/2020 and they are subject to change as new information is published.
This activity will discuss initiating opioids in acute and chronic pain, long term management of patients on opioid therapy, patient counseling, and fundamentals of addiction medicine. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 3/19/2020 and they are subject to change as new information is published.
Marijuana has become the new fashion statement of medicine. An illegal substance that was, in recent decades, described as the gateway drug, has now found a place within the pharmaceutical industry and the doctor’s office. To prescribe or not to prescribe? This lecture will help you answer that question with information on the proposed mechanisms of action, indications for use, and risks of using medical cannabis in pain management. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 6, 2020 and they are subject to change as new information is published.
Join us as we discuss the increased off-label use of gabapentinoids most likely in response to the treatment of pain.
Nonopioid therapy is an important tool for the treatment of chronic pain. But agents differ as to efficacy and safety in older patients. This program reviews the different classes of nonopioid medications, their efficacy in different types of pain, and their use in older patients. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).